Skip to main content

Maria Jose Pérez García

I am a senior researcher at the Vall d'Hebron Research Institute (VHIR). In addition to my research work, for the past decade, I have served as a coordinator and professor in the Master's in Translational Biomedical Research at VHIR.

Institutions of which they are part

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Biòloga
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital

Maria Jose Pérez García

Institutions of which they are part

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Biòloga
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital

I am a senior researcher at the Vall d'Hebron Research Institute (VHIR). In addition to my research work, for the past decade, I have served as a coordinator and professor in the Master's in Translational Biomedical Research at VHIR.

I graduated in Biochemistry from the University of the Balearic Islands (UIB) in 2000. During my predoctoral research, I focused on studying the mechanisms regulating the survival and death of motor neurons following neurotrophic factor withdrawal, as well as the crucial role of calcium in this process. Additionally, I undertook predoctoral stays both in Spain, at the University of Castilla-La Mancha, and abroad, at INSERM U.382 in Marseille, which expanded my perspective and experience in the research field.

After obtaining my doctorate, I continued my research career with a postdoctoral fellowship at Columbia University (USA), under the supervision of Dr. A.H. Kottmann, focusing on the study of amyotrophic lateral sclerosis (ALS). Subsequently, I joined Dr. Steve J. Burden's group at New York University (NYU), where I participated in projects related to fibroblast differentiation into myoblasts induced by MyoD expression, as well as in the analysis of MuSK receptor overexpression in a murine model of neuromuscular pathology.

In 2012, I joined Dr. Francina Munell's group in the field of Pediatric Neurology, through the Beatriz de Pinós program, conducting a project related to neuromuscular junctions in spinal muscular atrophy. Later, I joined the cell signaling and apoptosis group, led by Dr. Joan X Comella, where I supervised several projects and directed various doctoral theses. Currently, I am a senior researcher in the Pediatric Oncology group.

In addition to my research activities, I am actively involved in training postgraduate students as a teacher and coordinator of the Diseases of the Nervous System module in the Master's in Translational Biomedical Research at VHIR since 2014.

Projects

Papel del antagonista de receptores de muerte, FAIM-L en la progresión de la enfermedad de Alzheimer

IP: -
Collaborators: Joaquin Lopez Soriano, Maria Jose Pérez García, Antonio Palasi Franco
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 166980
Reference: PID2019-107286RB-I00
Duration: 01/06/2020 - 31/05/2023

Ministerio de Ciencia

Potencial terapéutico de los estrógenos en la enfermedad de Duchenne: efectos y mecanismos de acción sobre las células satélite y macrófagos

IP: Francina Munell Casadesus
Collaborators: Maria Jose Pérez García, Mireia Del Toro Riera, Elena Antima Martinez Saez
Funding agency: Instituto de Salud Carlos III
Funding: 57475
Reference: PI13/00052
Duration: 01/01/2014 - 30/09/2017

Rol de la neuromelanina y alfa-sinucleína en el inicio y extensión de la enfermedad de Parkinson: potencial diagnóstico y terapéutico en nuevos modelos pre-clínicos

IP: Miquel Vila Bover
Collaborators: Maria Jose Pérez García, Annabelle Parent
Funding agency: Instituto de Salud Carlos III
Funding: 142780
Reference: PI13/01897
Duration: 01/01/2014 - 30/06/2017

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The charitable initiative, launched by the Terrassa Municipal Police, funds the doctoral thesis of predoctoral researcher María Gallego.

The integration of Patient-Reported Outcome Measures (PROMs) will make it possible to incorporate patients' experiences and quality of life into research on sickle cell disease and other rare anaemias.

Related professionals

Anna Enrich  Font

Anna Enrich Font

Research technician
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Laia Closa Gil

Laia Closa Gil

Postdoctoral researcher
Transfusional Medicine
Read more
Rebeca Murillo Torres

Rebeca Murillo Torres

Research technician
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Susana  Manrique Muñoz

Susana Manrique Muñoz

Predoctoral researcher
Maternal and Fetal Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.